Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist

Similar documents
National Service Framework

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Clinical guideline for the management of atrial fibrillation

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Sudden death and inherited heart disease: a national plan. Dr Paul Brennan Lead Consultant in Cardiac Genetics Northern Genetics Service, UK

Specialised Services Policy Position PP151

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013

FANS Paediatric Pathway for Inherited Arrhythmias*

Asymptomatic WPW Syndrome; Observation or Ablation? 전남대학교병원순환기내과 박형욱

Management of Arrhythmias The General Practitioners role

2018 ESC Guidelines for the diagnosis and management of syncope

Quality Standards for the Implantation of Cardiac Rhythm Management Devices. Pan- London Arrhythmia Project Group. Version 3 (18 th July 2011)

Antony French Consultant Cardiologist & Electrophysiologist

CURRICULUM GOALS AND OBJECTIVES CLINICAL CARDIOVASCULAR ELECTROPHYSIOLOGY TRAINING PROGRAM. University of Florida Gainesville, Florida

EP WIRE on Management Preexcitation syndromes

Patient Resources: Arrhythmias and Congenital Heart Disease

ECG Workshop. Carolyn Shepherd And Anya Horne UWE Principles of Cardiac Care

AF and arrhythmia management. Dr Rhys Beynon Consultant Cardiologist and Electrophysiologist University Hospital of North Staffordshire

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Review guidance for patients on long-term amiodarone treatment

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

NICE Action Plan 6/13 Transient loss of consciousness ('blackouts') management in adults and young people NICE CG 109 December 2013

Audit support for continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (review of technology appraisal guidance 57)

21/06/2018. MEASURING PERFORMANCE (AUDIT AND QUALITY IMPROVEMENT) Towards Reducing Inequity. What should we be measuring?

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death

Dos and Don t in Cardiac Arrhythmia. Case 1 -ECG. Case 1. Management. Emergency Admissions. Reduction of TE risk -CHADS 2 score. Hospital Admissions

Ambulatory Cardiac Monitors and Outpatient Telemetry Corporate Medical Policy

Tachycardias II. Štěpán Havránek

Coronary Heart Disease

OVERVIEW OF ARRHYTHMIA

Setting up and running an effective Syncope Service

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Title Deactivation of Implantable Cardioverter Defibrillators (ICD) towards the end of life Guidelines

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

HERTS VALLEYS CCG PALLIATIVE AND END OF LIFE CARE STRATEGY FOR ADULTS AND CHILDREN

BSH Heart Failure Nurse and Healthcare Professional Study Day 2017

Chapter 16: Arrhythmias and Conduction Disturbances

Arrhythmias and Heart Failure Dr Chris Lang Consultant Cardiologist and Electrophysiologist Royal Infirmary of Edinburgh

BHRS Prep course Pub style Quiz NOT A

CASE STUDY: THE CLINICAL BENEFIT OF MOBILE CARDIAC OUTPATIENT TELEMETRY. June 22, 2009

What is an. arrhythmia?

Improving Patient Outcomes with a Syncope Center. Suneet Mittal, MD

Question 1: Between 1 July 2014 and 30 June 2015, in the area covered by your CCG:

CLINICAL CARDIAC ELECTROPHYSIOLOGY Maintenance of Certification (MOC) Examination Blueprint

Paroxysmal Supraventricular Tachycardia PSVT.

UNDERSTANDING ELECTROPHYSIOLOGY STUDIES

Arrhythmias. A/Prof Drew Richardson. The Canberra Hospital May MB BS (Hons) FACEM Grad CertHE MD

Costing Report: atrial fibrillation Implementing the NICE guideline on atrial fibrillation (CG180)

ACC/AHA Guidelines for Ambulatory Electrocardiography: Executive Summary and Recommendations

Dysrhythmias 11/7/2017. Disclosures. 3 reasons to evaluate and treat dysrhythmias. None. Eliminate symptoms and improve hemodynamics

STANDARDS FOR INTERVENTIONAL ELECTROPHYSIOLOGY STUDY AND CATHETER ABLATION IN ADULTS January 2014

Mission Statement for our Arrhythmia Care

National Coverage Determination (NCD) for Cardiac Pacemakers (20.8)

SCHEDULE 2 THE SERVICES. A. Service Specifications

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

C1: Medical Standards for Safety Critical Workers with Cardiovascular Disorders

requesting information regarding atrial fibrillation in NHS Ashford Clinical Commissioning Group

Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

Clinical Cardiac Electrophysiology

Case-Based Practical ECG Interpretation for the Generalist

Emergency Department Management of Patients with Implantable Cardioverter Defibrillators

ARRHYTHMIAS AND DEVICE THERAPY

PERIOPERATIVE MANAGEMENT: CARDIAC PACEMAKERS AND DEFIBRILLATORS

02/GMS/0030 ADULT EPILEPSY SERVICE CCP for General Medical and Surgical POOLE HOSPITAL NHS FOUNDATION TRUST

Atrial fibrillation. Understanding NICE guidance

New scientific documents from EHRA Management of patients with defibrillator shocks

Community Cardiology Service - Reinventing Care

PhD FRCP MESC MEAPCI. Consultant Cardiologist SVT - Supra Ventricular Tachycardia. Coronary Arteries

GOVERNING BODY REPORT

Guideline for the Management of patients with Regular Narrow-Complex Tachyarrhythmia

ECG S: A CASE-BASED APPROACH December 6,

SELF ASSESSMENT REPORT (MULTI-DISCIPLINARY TEAM)

Tilt test. Tilt test. The Heart Rhythm Charity

ESC Stockholm Arrhythmias & pacing

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Inappropriate electrical shocks: Tackling the beast

CLINICAL MEDICAL POLICY

Atrial Fibrillation Cases. Dr Paul Broadhurst Consultant Cardiologist

How to set up a device clinic for heart failure patients Dr C Sridevi

National Horizon Scanning Centre. Dronedarone (Multaq) for atrial fibrillation and atrial flutter. December 2007

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Arrhythmia Management Joshua M. Cooper, MD, FHRS, FACC

2010 Canadian Cardiovascular Society/ Canadian Heart Rhythm Society Training and Maintenance of Competency in Adult Clinical Cardiac

Young onset dementia service Doncaster

Remote Monitoring & the Smart Home of the 21 Century

How Do I Balance Bradycardia with Rate Control in Atrial Fibrillation?

APPROACH TO TACHYARRYTHMIAS

Saudi Council for Health Specialties

Public Health Perspective of Ventricular Arrhythmia Treatment. Dr Debbie Chase, Public Health Specialist Trainee, SCPCT

Transient loss of consciousness

Deactivating implantable cardiac defibrillators in end of life care. Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014

Cardiac Dysrhythmias and Sports

SERVICE SPECIFICATION 6 Conservative Management & End of Life Care

Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof of Cardiology, University Hospital of Crete

SVT Discriminators. Definition of SVT Discrimination. Identify which patient populations might benefit from these features

Proof of Concept: NHS Wales Atlas of Variation for Cardiovascular Disease. Produced on behalf of NHS Wales and Welsh Government

2010 National Audit of Dementia (Care in General Hospitals)

Cardiac Considerations and Care in Children with Neuromuscular Disorders

Cardiac Implanted Electronic Devices Pacemakers, Defibrillators, Cardiac Resynchronization Devices, Loop Recorders, etc.

Transcription:

Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist

LOTS!!! This presentation confines itself to the situation in the North West. The views expressed are my personal views. Relationship with Primary and Tertiary Care not forgotten but in view remit of title and time limit of presentation limited discussion only. Apologies in advance if there is significant repetition of themes from previous presentations!

Arrhythmia Care in the DGH NSF Chapter 8 Quality Requirements excellent Are they being implemented? NICE guidance is it being fully implemented? Large inequalities geographically in all aspects of care What s being done about this?

Quality Requirement 1: Patient Support People with arrhythmias receive a formal assessment of their support needs and those at significantly increased risk of anxiety, depression or a poor quality of life receive appropriate care. People with long-term conditions receive support in managing their illness from a named arrhythmia care co-ordinator. Good quality, timely information about arrhythmic conditions is given by appropriately trained staff.

Quality Requirement 1: Patient Support People with arrhythmias receive a formal assessment of their support needs and those at significantly increased risk of anxiety, depression or a poor quality of life receive appropriate care. Care tends to be focussed on those patients having interventions (eg ICD etc.) and mainly through tertiary centres Little or no formal support for other groups

Quality Requirement 1: Patient Support People with long-term conditions receive support in managing their illness from a named arrhythmia care co-ordinator. These posts are currently virtually non-existant in the DGH setting apart from BHF funded nurses on a network level

Quality Requirement 1: Patient Support Good quality, timely information about arrhythmic conditions is given by appropriately trained staff. If patients seen by a Cardiologist or who enter Cardiac Rehabilitation post MI/Revascularisation, then usually appropriate information given Patients not seen by a Cardiologist receive very variable information

Quality Requirement 2: Diagnosis and Treatment guidance on making the initial diagnosis and on management by readily accessible approved algorithms; improving access to a higher level of expertise by development of rapid access multidisciplinary arrhythmia and/or blackouts clinics focused education of key carers improving access to diagnostics at all stages improving acquisition, storage and availability of clinical information such as ECGs and audit of all interventions.

Quality Requirement 2: Diagnosis and Treatment guidance on making the initial diagnosis and on management by readily accessible approved algorithms Work on clinical pathways being done on a national and network level but implementation slow

Quality Requirement 2: Diagnosis and Treatment improving access to a higher level of expertise by development of rapid access multidisciplinary arrhythmia and/or blackouts clinics Very few specialised clinics being set up in DGH s apart from in atrial fibrillation care with Care of the Elderly physicians At present most cases seen in General Cardiology clinics

Quality Requirement 2: Diagnosis and Treatment focused education of key carers Again predominantly successful around patients needing interventions or in the post MI/revascularisation patients entering cardiac rehabilitation Other groups still not well served

Quality Requirement 2: Diagnosis and Treatment improving access to diagnostics at all stages As part of 18 week strategy improvement in diagnostics has been targeted by all healthcare organisations Specific diagnostic interventions such as implantable loop recorders etc still problematic re DGH funding.

Quality Requirement 2: Diagnosis and Treatment Markers of Good Practice Markers of Good Practice All patients receive a hard copy of the ECG documenting their arrhythmia and a copy is placed in their records. Being done variably unless patient seen in Cardiology clinics and even then accurate data not available Patients who survive out-of-hospital cardiac arrest and patients presenting with pre-excited atrial fibrillation are assessed by a heart rhythm specialist prior to hospital discharge. Most patients are being referred but accurate data not available

Quality Requirement 2: Diagnosis and Treatment Markers of Good Practice Markers of Good Practice The following patients are assessed urgently by a heart rhythm specialist: Patients with syncope or any other symptom(s) suggestive of an arrhythmia and a personal history of structural heart disease or a family history of premature sudden death Patients with recurrent syncope associated with palpitations Patients with syncope and pre-excitation if recognised Patients with documented 3rd degree AV block (not associated with acute MI) Patients with recurrent syncope in whom a life-threatening cause has not been excluded Patients with documented ventricular tachycardia

Quality Requirement 2: Diagnosis and Treatment Markers of Good Practice The following patients are referred to a heart rhythm specialist: Patients with a presumed diagnosis of ventricular tachycardia Patients with Wolff-Parkinson-White (WPW) syndrome or asymptomatic pre-excitation Patients with symptomatic regular recurrent supraventricular tachycardia which is unsuccessfully treated with one type of medication or who would prefer not to take long-term medication Patients with recurrent atrial flutter Patients with symptomatic atrial fibrillation despite optimal medical therapy First degree relatives of victims of sudden cardiac death who died below the age of 40 years Patients with recurrent unexplained falls

Quality Requirement 2: Diagnosis and Treatment Markers of Good Practice Ongoing Treatment Mechanisms are in place for urgent referral of patients with sustained or compromising arrhythmias for prioritisation of appropriate treatment. ICDs are considered in patients presenting with life-threatening ventricular arrhythmias and in those without demonstrable arrhythmia but identified as being at high risk. Catheter ablation is considered as the treatment of choice in patients presenting with sustained supraventricular tachycardia (SVT) other than atrial fibrillation, and cardioversion of recent onset atrial fibrillation (AF) is considered as early as is clinically safe. Where further hospital treatment is not recommended, a care plan is agreed between the patient, GP and the arrhythmia care team, including follow up and support as required.

Quality Requirement 3: Sudden Cardiac Death When sudden cardiac death occurs, NHS services have systems in place to identify family members at risk and provide personally tailored, sensitive and expert support, diagnosis, treatment, information and advice to close relatives.

Quality Requirement 3: Sudden Cardiac Death When sudden cardiac death occurs, NHS services have systems in place to identify family members at risk and provide personally tailored, sensitive and expert support, diagnosis, treatment, information and advice to close relatives.

Quality Requirement 3: Sudden Cardiac Death Individuals who experience episodes of sustained palpitation and/or unexplained impaired consciousness, particularly if repeated or triggered by exercise, have rapid access to cardiac evaluation, including 12-lead and continuous ECG monitoring and 2D echocardiography. Suitable bereavement services are available for those who have lost a family member. An expert post mortem is carried out and appropriate tissue retained if informed consent is given. Evaluation of families who may have inherited cardiac disease takes place in a dedicated clinic, with staff who are trained in diagnosis, management and support for these families. Genetic counselling and further testing is available if appropriate.

Cardiac Pacing and Devices Still low levels of implantation of standard bradycardia devices (pacemakers) let alone advanced devices (eg( ICD s) Large inequalities in provision

The Challenges Everything seems to move at glacial pace! Frustration. Large numbers of items to address Inadequate numbers of trained staff No targeted resource Competing for resources with many other worthy causes Fragmentation / Competition between providers vs Collaborative / Network planning Inequalities geographical, socio-economic, ethnic etc.

The Drivers for Change 18 weeks NICE Ensure audit of NICE approved guidance and target delivery (eg( ICD s,, Atrial Fibrillation, Heart Failure etc). Engage with PCTs on delivery of current NICE approved guidance in a planned/structured fashion.

Education Healthcare staff Education PCTs/Acute Trusts Education Population including existing patient support groups for IHD.

Networking Use Cardiac Networks to prioritise the order of competing priorities. Develop complete pathways of care that can the be put forward for funding. Action likely to be quicker if chapter 8 priorities become Healthcare Commission priorities.